期刊文献+

乙型肝炎组织精氨酸酶1的表达与其组织学分级的相关性 被引量:2

Association of arginase-1 expression with histological grading and staging in type B hepatitis
原文传递
导出
摘要 目的研究精氨酸酶1(Arg-1)在乙型肝炎组织中的表达及与炎症和纤维化分级的相关性。方法 HBsAg阳性肝穿刺及手术标本118例,按肝炎修正HAI记分法分为G0-G4级和S0-S4期,用Western blot检测Arg-1蛋白在G0,G4,S0,S4组中的表达;用免疫组织化学检测Arg-1在G0,G1,G2,G3,G4及S0,S1,S2,S3,S4各组中的表达。结果 Arg-1在G0、S0组高表达,在G4、S4组表达水平明显降低。Arg-1弥漫表达于G0、S0组肝细胞胞浆和部分肝细胞胞核,门管区肝细胞表达更为明显;随着炎症和纤维化程度增加,Arg-1表达强度逐渐降低,且表达强度与炎症和纤维化分级呈负相关(P<0.01)。结论 Arg-1与乙型肝炎病理生理过程密切相关,可以作为乙型肝炎组织学分级的一项参考指标。 Objective To investigate the relationship between arginase-1 (Arg-1) expression and the histological grading and staging in hepatitis B patients. Methods Tissue specimens were collected from 118 hepatitis B patients with HBsAg-positive. The specimens were divided into groups of GO, G1, G2, G3, G4, SO, S1, S2, S3 and S4 according to HAI scoring method. Western blot was used to detect Arg-1 expression in groups of GO, G4, SO and S4. Immunohistochemical staining was performed to detect Arg-1 expression in all groups. Results There was a high Arg-1 expression in groups of GO and SO. A significant decrease of Arg-1 activity was observed in groups of G4 and S4. Arg-1 in groups of GO and SO was diffusely expressed in cytoplasma of hepatocytes and occasionally of nuclear,especially in periportal hepatocytes. Arg-1 expression was decreased as hepatic inflammation and fibrosis were increased. There was a negative correlation between Arg-1 expression and histological grading and staging(P〈0. 01). Conclusion Arg-1 expression is closely associated with pathophysiological process of hepatitis B patients, which may be taken as an indicator for histologically grading and staging in the patients with hepatitis B.
出处 《江苏医药》 CAS 北大核心 2013年第1期68-70,共3页 Jiangsu Medical Journal
基金 南通市社会事业科技创新与示范计划(HS2011049)
关键词 精氨酸酶1 乙型肝炎 Arginase-1 Type B hepatitis
  • 相关文献

参考文献10

  • 1Spector EB,Jenkinson CP, Grigor MR, et al. Subcellularlocation and differential antibody specificity of arginase intissue culture and whole animals [J]. Int J Dev Neurosci,1994,12(4):337-342.
  • 2Chrzanowska A, Gajewska B, Baranczyk-Kuana A. Arginaseisoenzymes in human cirrhotic liver[J].Acta Biochim Pol,2009,56(3):465-469.
  • 3Rosai J. Rosai Ackerman 外科病理学[M].田允中,译.第9版.北京大学医学出版社,2006:927-928.
  • 4朱颖炜,龚镭,范丽,吴梦颖,谈春晓,王昕炜,傅美丽,吴高珏.纤溶酶原激活物抑制剂1在肝纤维化组织中的表达及意义[J].江苏医药,2011,37(5):559-561. 被引量:7
  • 5Sekine S,Ogawa R,Mcmanus MT,et al. Dicer is required forproper liver zonation[J]. J Pathol,2009,219(3) -.365-372.
  • 6Pesce JT,Ramalingam TR, Mentink-Kane MM, et al.Arginase-l-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis[J], PLoS Pathog,2009,5(4):el000371.
  • 7Miki K, Kumar A, Yang R, et al. Extracellular activation ofarginase-1 decreases enterocyte inducible nitric oxide synthaseactivity during systemic inflammation [ J ]. Am J PhysiolGastrointest Liver Physiol, 2009?297 (4) :G840-G848.
  • 8Crombez EA,Cederbaum SD. Hyperargininemia due to liverarginase deficiency[J]. Mol Genet Metab, 2005,84 (3) : 243-251.
  • 9Marini JC, Keller B, Didelija IC,et al. Enteral arginase IIprovides ornithine for citrulline synthesis[J]. Am J PhysiolEndocrinol Metab,2011,300(1) :E188-E194.
  • 10Endo M, Oyadomari S, Terasaki Y, et al. Induction ofarginase I and II in bleomycin-induced fibrosis of mouse lung[J]. Am J Physiol Lung Cell Mol Physiol,2003’ 285 (2):L313-L321.

二级参考文献5

  • 1Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis an therapeutic implications[J]. Nat Clin Praet Gastro- enterol Hepatol, 2004,1 (2) : 98-105.
  • 2Huang Y, Haraguchi M,Lawrence DA, et al. A mutant,nonin- hibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis[J]. Clin Invest, 2003,112 (3) :379-388.
  • 3Zhang LP, Takahara T,Yata Y,et al. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats., role of stellate cells[J]. J Hepatol, 1999,31(4) : 703-711.
  • 4Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells[J]. Semin Liver Dis, 2001,21 (3) : 373-384.
  • 5Andreasen PA, Kjoller L, Christensen L. The urokinase-type plasminogen activator system in cancer metastasis: a review [J]. Int J Cancer, 1997,72(1) : 1-22.

共引文献7

同被引文献44

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部